STUDY DESIGN: A decision-analytic model was constructed using TreeAge to compare outcomes in infants affected by NOW. We used a theoretical cohort of 23,200 neonates (an estimate of the annual number of births affected by NOW in the US). The strategies compared are rooming-in versus not rooming-in and breastfeeding versus formula in evaluating the need for pharmacologic treatment. Primary outcomes were length of stay and neurodevelopment. We undertook a societal perspective over a lifetime, and all costs are expressed in 2018 US dollars. Effectiveness was based on combined maternal and neonatal quality-adjusted life years (QALYs). A costeffectiveness threshold was set at $100,000/QALY. All model inputs were derived from the literature and varied in sensitivity analyses to assess the robustness of the model. RESULTS: Rooming-in increased the likelihood of breastfeeding and resulted in fewer neonates requiring pharmacologic intervention. Rooming-in resulted in cost savings of $349,543,960 and 7,888 additional QALYs (Table) . When the probability of pharmacologic treatment was varied, rooming-in remained the dominant strategy with lower costs and increased effectiveness ( Figure) . CONCLUSION: Rooming-in with infants affected by NOW promotes breastfeeding and decreases the need for pharmacologic treatment thereby mitigating neurodevelopmental sequelae. Management strategies in this population should focus on optimizing non-pharmacologic interventions. OBJECTIVE: 24 states impose gestational-age limits on abortion, with 17 banning abortion at 20 weeks post-fertilization or its equivalent of 22 weeks LMP. Our objective was to characterize fetal indications for abortion at 22 weeks at our institution, and to compare indications for abortion in these women to those undergoing abortion earlier in the 2nd trimester. STUDY DESIGN: We identified patients receiving prenatal care at our institution from 2012-2017 who underwent abortion at 15 weeks' gestation. Medical record review identified clinical factors including indications for abortion. A fetal anomaly was categorized as "Genetic" if the genetic disorder was the initial diagnosis. If a major structural anomaly led to a genetic diagnosis, the structural anomaly was considered the initial diagnosis. Fisher's exact test and chi-square were used to compare those undergoing abortion 22 weeks vs. 15-21 weeks. RESULTS: 168 women underwent abortion for fetal indications at 15 weeks, with 64 (38%) at 22 weeks. Indications are in the Table. While genetic disorders were more common at 15-21 weeks (42% vs. 16% p<.001), CNS anomalies (30% vs. 12%; p¼.008) and IUGR (12% vs. 3%; p¼.02) were more common at 22 weeks. 50% of those with structural anomalies at 15-21 had ultrasound early in the 2nd trimester compared to only 7% in those undergoing abortion at 22 weeks (p<.001), with abnormal 1st-trimester ultrasound and high MSAFP the most common indications. In those diagnosed at routine anatomy scan, those undergoing abortion at 22 weeks were more likely to have this scan at >20.0 weeks (60 vs. 11%; p<.001). Genetic disorders in the 15-21 week group were more likely to be conditions screened for compared to those at 22 weeks (52% vs. 17%; p¼.005), and 3 of 4 common abnormalities in the 22 week group had false-negative screening. CONCLUSION: Abortions performed at 22 weeks for fetal indications were more likely to involve structural anomalies compared to those performed at 15-21 weeks, in whom genetic disorders were most common. Most genetic disorders in those undergoing earlier abortion were conditions routinely screened for. While improvements in genetic screening and referring high-risk patients for early 2nd trimester ultrasound can lead to earlier abortion, conditions in patients without risk factors may go unsuspected until late in the 2nd trimester. Earlier 2nd-trimester ultrasound may be necessary to expedite prenatal diagnosis if gestational age limitations on abortion are enforced. OBJECTIVE: The objective of this study was to characterize the risk for severe maternal morbidity by maternal age during delivery hospitalizations for twin pregnancies. STUDY DESIGN: This retrospective cohort study utilized the Nationwide Inpatient Sample (NIS) from the Agency for Healthcare Research and Quality for the years 1998 to 2014. Women aged 15 to 54 hospitalized for delivery with a diagnosis of a twin pregnancy were included. Age was categorized as 15-17, 18-24, 25-29, 30-34, 35-39, 40-44, and 45-54 years. The overall risk for severe morbidity (SMM) based on Centers for Disease Control and Prevention criteria was analyzed stratified by maternal age, along with the risk for specific outcomes including disseminated intravascular coagulation (DIC) and hysterectomy. SMM was assessed with and without transfusion. Log-linear models were created to assess the risk for ajog.org
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